These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2468056)

  • 1. Infusion of atrial natriuretic peptide to patients with congestive heart failure.
    Goy JJ; Waeber B; Nussberger J; Bidiville J; Biollaz J; Nicod P; Mooser V; Kappenberger L; Brunner HR
    J Cardiovasc Pharmacol; 1988; 12(5):562-70. PubMed ID: 2468056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
    Franco-Saenz R; Somani P; Mulrow PJ
    Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
    Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
    J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.
    Petrillo A; Scherrer U; Gonvers JJ; Nussberger J; Marder H; de Vane P; Waeber B; Hofstetter JR; Brunner HR
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):279-85. PubMed ID: 2464099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
    Lewis BS; Makhoul N; Dakak N; Flugelman MY; Yechiely H; Halon DA; Kahana L
    Am Heart J; 1992 Oct; 124(4):1009-16. PubMed ID: 1388322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic, hormonal, and renal effects of atrial natriuretic peptide in untreated congestive cardiac failure.
    Anand IS; Kalra GS; Ferrari R; Harris P; Poole-Wilson PA
    Am Heart J; 1989 Sep; 118(3):500-5. PubMed ID: 2528277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
    Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
    Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of atrial peptide infusion in heart failure.
    Crozier IG; Nicholls MG; Ikram H; Espiner EA; Gomez HJ; Warner NJ
    Lancet; 1986 Nov; 2(8518):1242-5. PubMed ID: 2878131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of atrial natriuretic peptide in patients with acute heart failure.
    Kitashiro S; Sugiura T; Takayama Y; Tsuka Y; Izuoka T; Tokunaga S; Iwasaka T
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):948-52. PubMed ID: 10367599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide as a preload depressor in acute renal failure secondary to congestive heart failure.
    Seta K; Hayashi T; Sugawara A; Kasuno K; Watanabe S; Sumi Y; Kijima Y; Kawaguchi K; Kotake C; Seo T; Toda T; Kuwahara T
    Ren Fail; 1998 Sep; 20(5):717-23. PubMed ID: 9768440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressor hormones regulate atrial-stretch-induced release of atrial natriuretic peptide in the pithed rat.
    Ruskoaho H; Vakkuri O; Arjamaa O; Vuolteenaho O; Leppäluoto J
    Circ Res; 1989 Mar; 64(3):482-92. PubMed ID: 2563674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides in the treatment of heart failure.
    Yasue H; Yoshimura M
    J Card Fail; 1996 Dec; 2(4 Suppl):S277-85. PubMed ID: 8951590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
    Pesonen A; Leppäluoto J; Ruskoaho H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.
    Saito Y; Nakao K; Nishimura K; Sugawara A; Okumura K; Obata K; Sonoda R; Ban T; Yasue H; Imura H
    Circulation; 1987 Jul; 76(1):115-24. PubMed ID: 2954723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the levels of plasma atrial natriuretic peptide, hemodynamic measurements, and the levels of vasoactive hormones during the clinical course of congestive heart failure.
    Hara H; Ogihara T; Nakamaru M; Rakugi H; Tateyama H
    Clin Cardiol; 1988 Nov; 11(11):743-7. PubMed ID: 2976625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.